Immunicum AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.12.21	Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study (GlobeNewswire)
30.11.21	Immunicum and PCI Biotech Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments (GlobeNewswire)
22.11.21	Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells (GlobeNewswire)
09.11.21	Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
04.11.21	Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH) (GlobeNewswire)
03.11.21	Immunicum Announces Nomination Committee for the 2022 Annual General Meeting (GlobeNewswire)
01.11.21	Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November (GlobeNewswire)
28.10.21	Immunicum to Host Investor Meeting with CEO (GlobeNewswire)
28.10.21	Immunicum AB (publ) Interim Report July - Sep 2021 (GlobeNewswire)
26.10.21	Immunicum Appoints Lotta Ferm as Chief Financial Officer (GlobeNewswire)
30.09.21	Immunicum Appoints New Experts in Cancer Immunology to Scientific Advisory Board (GlobeNewswire)
29.09.21	Immunicum AB (publ) Announces Outcome of Subscription in Incentive Program LTI 2021/2024 (GlobeNewswire)
08.09.21	Immunicum and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer Relapse Vaccine Development for Ovarian Cancer (GlobeNewswire)
27.08.21	Immunicum Announces Participation in Multiple Upcoming Industry and Investor Events in September and October (GlobeNewswire)
26.08.21	Immunicum AB (publ) Interim Report April - June 2021 (GlobeNewswire)
26.07.21	Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study (GlobeNewswire)
30.06.21	Change in Number of Shares and Votes in Immunicum AB (publ) (GlobeNewswire)
28.06.21	Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001 (GlobeNewswire)
23.06.21	Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer (GlobeNewswire)
17.06.21	Immunicum Announces Results of Directed Share Issue (GlobeNewswire)
17.06.21	Immunicum Announces its Intention to Carry Out a Directed Share Issue (GlobeNewswire)
11.06.21	Immunicum Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual Congress (GlobeNewswire)
12.05.21	Immunicum Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress (GlobeNewswire)
04.05.21	Report from the Annual General Meeting of Immunicum AB (publ) on 4 May 2021 (GlobeNewswire)
04.05.21	Immunicum AB (publ) Interim Report January – March 2021 (GlobeNewswire)
03.05.21	Immunicum AB Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeting (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Immunicum AB

Aktien Top/Flop

Meistgelesene Nachrichten